A Rising Crisis: Escalating Burden of Diabetes Mellitus and Hypertension‐Related Mortality Trends in the United States, 2000–2023
Year: 2025
Type: article
Study design: Observational Study
Abstract: INTRODUCTION: Diabetes mellitus and hypertension are major contributors to cardiovascular and renal disease mortality, yet their combined long-term impact on mortality trends in the United States remains underexplored. This study evaluates national trends in DM and hypertension-related mortality from 2000 to 2023, analyzing disparities across sex, age groups, race/ethnicity, urbanization, and geographic regions. METHODS: We analyzed mortality data from the CDC-WONDER database, identifying deaths with DM and hypertension as listed causes among adults aged 25 and older. Age-adjusted mortality rates (AAMRs) per 100,000 were calculated, and temporal trends were assessed using Joinpoint regression to determine annual percentage changes. RESULTS: A total of 2,742,668 DM and hypertension-related deaths were recorded. The AAMR nearly doubled from 33.7 per 100,000 in 2000 to 66.2 per 100,000 in 2023. A sharp increase was observed from 2018 to 2021 (APC: 16.3 [95% CI: 11.8-19.6]), followed by a decline through 2023. Men had consistently higher mortality rates than females. Mortality rates were highest among older adults (65+ years), Non-Hispanic Black individuals, and nonmetropolitan populations. The South had the highest mortality rates, with Mississippi and the District of Columbia reporting the greatest burden. CONCLUSIONS: DM and hypertension-related mortality has significantly increased over the past two decades, with notable demographic and geographic disparities. Public health interventions should prioritize high-risk populations to mitigate mortality trends and improve health equity.
Source: Clinical Cardiology
DOI: 10.1002/clc.70167
Authors: Hibah Siddiqui, Zahra Imran, Dua Ali, Maryam Sajid, Taimor Mohammed Khan, Hussain Salim, Muhammad Salik Uddin, Shaheer Qureshi, Muzammil Farhan, Saad Ahmed Waqas
Institutions: Dow University of Health Sciences, Imperial College London
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,810
OpenAlex ID: W4411959731
